SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab

I. Meattini, G. Curigliano, F. Terziani, C. Becherini, M. Airoldi, G. Allegrini, D. Amoroso, S. Barni, C. Bengala, V. Guarneri, P. Marchetti, F. Martella, P. Piovano, A. Vannini, I. Desideri, R. Tarquini, G. Galanti, G. Barletta, L. Livi

Research output: Contribution to journalArticlepeer-review

Cite this